Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Vitamin D supplements increased ovulation rates in women with PCOS who were vitamin D deficient.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Early balding linked to higher heart disease risk.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Weight loss improves PCOS symptoms and overall health.

Silymarin and metformin together most improved hormone levels and ovulation in women with PCOS.

Most women with Polycystic Ovary Syndrome (PCOS) have skin issues like excessive hair, acne, or hair loss. Hormone imbalances are common, and age, certain hormones, and hormone ratios can predict acne. Obesity, infertility, and high cholesterol are also common in these women.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Lifestyle changes and insulin-sensitizing drugs are effective for managing PCOS.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.